167 related articles for article (PubMed ID: 35415787)
1. Establishment and validation of a nomogram for predicting potential lateral pelvic lymph node metastasis in low rectal cancer.
Sumii A; Hida K; Sakai Y; Hoshino N; Nishizaki D; Akagi T; Fukuda M; Yamaguchi T; Takemasa I; Tokunaga T; Watanabe J; Watanabe M
Int J Clin Oncol; 2022 Jul; 27(7):1173-1179. PubMed ID: 35415787
[TBL] [Abstract][Full Text] [Related]
2. Establishing and validating predictive nomograms for lateral pelvic lymph node metastasis in patients with rectal cancer based on radiologic factors and clinicopathologic characteristics.
Zhou S; Yang Y; Lou Z; Liang J; Wang X; Tang J; Liu Q;
Eur J Surg Oncol; 2023 Apr; 49(4):747-754. PubMed ID: 36604232
[TBL] [Abstract][Full Text] [Related]
3. Establishment and validation of nomograms for predicting mesorectal lymph node staging and restaging.
Zhuang Z; Ma X; Zhang Y; Yang X; Wei M; Deng X; Wang Z
Int J Colorectal Dis; 2022 Sep; 37(9):2069-2083. PubMed ID: 36028723
[TBL] [Abstract][Full Text] [Related]
4. The important risk factor for lateral pelvic lymph node metastasis of lower rectal cancer is node-positive status on magnetic resonance imaging: study of the Lymph Node Committee of Japanese Society for Cancer of the Colon and Rectum.
Ogawa S; Hida J; Ike H; Kinugasa T; Ota M; Shinto E; Itabashi M; Okamoto T; Sugihara K
Int J Colorectal Dis; 2016 Oct; 31(10):1719-28. PubMed ID: 27576475
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study.
Oh HK; Kang SB; Lee SM; Lee SY; Ihn MH; Kim DW; Park JH; Kim YH; Lee KH; Kim JS; Kim JW; Kim JH; Chang TY; Park SC; Sohn DK; Oh JH; Park JW; Ryoo SB; Jeong SY; Park KJ
Ann Surg Oncol; 2014 Jul; 21(7):2280-7. PubMed ID: 24604580
[TBL] [Abstract][Full Text] [Related]
6. Combination of extramural venous invasion and lateral lymph node size detected with magnetic resonance imaging is a reliable biomarker for lateral lymph node metastasis in patients with rectal cancer.
Abe T; Yasui M; Imamura H; Matsuda C; Nishimura J; Haraguchi N; Nakai N; Wada H; Takahashi H; Omori T; Miyata H; Ohue M
World J Surg Oncol; 2022 Jan; 20(1):5. PubMed ID: 34986842
[TBL] [Abstract][Full Text] [Related]
7. Development and External Validation of a Preoperative Nomogram for Predicting Lateral Pelvic Lymph Node Metastasis in Patients With Advanced Lower Rectal Cancer.
Zhang L; Shi F; Hu C; Zhang Z; Liu J; Liu R; She J; Tang J
Front Oncol; 2022; 12():930942. PubMed ID: 35880161
[TBL] [Abstract][Full Text] [Related]
8. A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies.
Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Fossati N; Stabile A; Beauval JB; Malavaud B; Roumiguié M; Robesti D; Dell'Oglio P; Moschini M; Zamboni S; Rakauskas A; De Cobelli F; Porpiglia F; Montorsi F; Briganti A
Eur Urol; 2019 Mar; 75(3):506-514. PubMed ID: 30342844
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors of pathological lateral pelvic lymph node metastasis in patients without clinical lateral pelvic lymph node metastasis (clinical stage II/III): The analysis of data from the clinical trial (JCOG0212).
Komori K; Fujita S; Mizusawa J; Kanemitsu Y; Ito M; Shiomi A; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Bandou H; Katsumata K; Kinugasa Y; Takii Y; Akasu T; Moriya Y;
Eur J Surg Oncol; 2019 Mar; 45(3):336-340. PubMed ID: 30477950
[TBL] [Abstract][Full Text] [Related]
10. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.
Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F
Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120
[TBL] [Abstract][Full Text] [Related]
11. [A nomogram for predicting lymph node metastasis in early gastric cancer].
Cui H; Cao B; Deng H; Liu GB; Liang WQ; Xie TY; Ye L; Zhang QP; Wang N; Liu FD; Wei B
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jan; 25(1):40-47. PubMed ID: 35067033
[No Abstract] [Full Text] [Related]
12. A predictive nomogram improved diagnostic accuracy and interobserver agreement of perirectal lymph nodes metastases in rectal cancer.
Liu Y; Wang R; Ding Y; Tu S; Liu Y; Qian Y; Xu L; Tong T; Cai S; Peng J
Oncotarget; 2016 Mar; 7(12):14755-64. PubMed ID: 26910373
[TBL] [Abstract][Full Text] [Related]
13. Lateral pelvic lymph node metastasis in T2 low rectal cancer: is TME alone sufficient for cure?
Ouchi A; Inoue M; Sato Y; Takamizawa Y; Kinoshita T; Moritani K; Komori K; Tsukamoto S; Shimizu Y; Kanemitsu Y
Jpn J Clin Oncol; 2023 Apr; 53(5):386-392. PubMed ID: 36722355
[TBL] [Abstract][Full Text] [Related]
14. Lateral pelvic lymph node dissection can be omitted in lower rectal cancer in which the longest lateral pelvic and perirectal lymph node is less than 5 mm on MRI.
Ogawa S; Itabashi M; Hirosawa T; Hashimoto T; Bamba Y; Kameoka S
J Surg Oncol; 2014 Mar; 109(3):227-33. PubMed ID: 24165955
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: a propensity score matching study.
Zhou S; Jiang Y; Pei W; Liang J; Zhou Z
BMC Cancer; 2022 Feb; 22(1):136. PubMed ID: 35109810
[TBL] [Abstract][Full Text] [Related]
16. [Lateral pelvic lymph node metastasis is an important prognostic factor for low rectal cancer].
Pan YS; Wan YL; Liu YC; Wang X; Wu T
Zhonghua Wai Ke Za Zhi; 2009 Jul; 47(13):984-7. PubMed ID: 19957807
[TBL] [Abstract][Full Text] [Related]
17. Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer.
Gandaglia G; Fossati N; Zaffuto E; Bandini M; Dell'Oglio P; Bravi CA; Fallara G; Pellegrino F; Nocera L; Karakiewicz PI; Tian Z; Freschi M; Montironi R; Montorsi F; Briganti A
Eur Urol; 2017 Oct; 72(4):632-640. PubMed ID: 28412062
[TBL] [Abstract][Full Text] [Related]
18. External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection.
Gandaglia G; Martini A; Ploussard G; Fossati N; Stabile A; De Visschere P; Borgmann H; Heidegger I; Steinkohl F; Kretschmer A; Marra G; Mathieu R; Surcel C; Tilki D; Tsaur I; Valerio M; Van den Bergh R; Ost P; Gontero P; Montorsi F; Briganti A;
Eur Urol; 2020 Aug; 78(2):138-142. PubMed ID: 32268944
[TBL] [Abstract][Full Text] [Related]
19. Prediction of lateral pelvic lymph node metastasis from lower rectal cancer using magnetic resonance imaging and risk factors for metastasis: Multicenter study of the Lymph Node Committee of the Japanese Society for Cancer of the Colon and Rectum.
Ogawa S; Hida JI; Ike H; Kinugasa T; Ota M; Shinto E; Itabashi M; Okamoto T; Yamamoto M; Sugihara K; Watanabe T
Int J Colorectal Dis; 2017 Oct; 32(10):1479-1487. PubMed ID: 28762189
[TBL] [Abstract][Full Text] [Related]
20. Correlations between the Recurrence Patterns and Sizes of Lateral Pelvic Lymph Nodes before and after Chemoradiotherapy in Patients with Lower Rectal Cancer.
Shiratori H; Kawai K; Hata K; Tanaka T; Nishikawa T; Sasaki K; Kaneko M; Murono K; Emoto S; Morikawa T; Fukayama M; Nozawa H
Oncology; 2019; 96(1):33-43. PubMed ID: 30212816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
